NRBO Stock Earnings NeuroBo Pharmaceuticals Misses EPS for Q2 2024
| NRBODelisted Stock | USD 2.36 0.01 0.43% |
About 62% of Neurobo Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Neurobo Pharmaceuticals suggests that many traders are alarmed. Neurobo Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Neurobo Pharmaceuticals. Many technical investors use Neurobo Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Neurobo |
NRBO stock results show that NeuroBo Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.
Read at investorplace.com
 |
Neurobo Pharmaceuticals Fundamental Analysis
We analyze Neurobo Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Neurobo Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Neurobo Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Neurobo Pharmaceuticals is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Neurobo Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Neurobo Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Neurobo Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Neurobo Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Neurobo Pharmaceuticals Related Equities
| BDRX | Biodexa Pharmaceticals | 14.00 | ||||
| PHIO | Phio Pharmaceuticals | 3.03 | ||||
| ATNF | 180 Life | 1.83 | ||||
| QNRX | Quoin Pharmaceuticals | 1.69 | ||||
| ZURA | Zura Bio | 1.67 | ||||
| REVB | Revelation Biosciences | 1.33 | ||||
| ALLR | Allarity Therapeutics | 0.90 | ||||
| SONN | Sonnet Biotherapeutics | 2.28 | ||||
| CDIO | Cardio Diagnostics | 3.23 | ||||
| VRAX | Virax Biolabs | 4.83 | ||||
| KPRX | Kiora Pharmaceuticals | 8.68 |
Check out Neurobo Pharmaceuticals Hype Analysis, Neurobo Pharmaceuticals Correlation and Neurobo Pharmaceuticals Performance. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Neurobo Stock
If you are still planning to invest in Neurobo Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neurobo Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |